Wegovy

Wegovy begins working after your first dose, but noticeable weight loss may take several weeks. The medication’s effects on appetite are gradual as you follow a dose escalation schedule. Most people see significant results after several months of consistent use combined with diet and exercise. Patience is key when starting this long-term treatment.

Wegovy can be injected at any time of day, with or without meals, on the same day each week. The most important factor is consistency. Choose a time that is most convenient for you and helps you remember to take your dose. You can change your injection day if needed, as long as the last dose was taken at least two days prior.

If you miss a dose of Wegovy, you should take it as soon as you remember, as long as your next dose is more than two days (48 hours) away. If your next dose is less than two days away, you should skip the missed dose entirely. Resume your regular schedule and do not take two doses to make up for the missed one.

Wegovy’s direct interaction with alcohol has not been formally studied, so caution is advised. Alcohol is high in calories and can work against weight loss efforts. It can also impact blood sugar levels. It is best to limit your alcohol intake and discuss your consumption habits with your doctor before starting Wegovy.

Wegovy pens must be stored in a refrigerator (36°F to 47°F or 2°C to 8°C) before the first use. After you take the first injection, the pen can be kept at room temperature (below 86°F or 30°C) or in the refrigerator for up to 56 days. It is very important that you do not freeze Wegovy.

Wegovy is approved for long-term, chronic weight management, not for short-term use. You and your healthcare provider will decide how long you should continue treatment. Many patients remain on the medication long-term to maintain their weight loss, as stopping the drug often leads to weight regain. Regular check-ins will determine the right duration for you.

Wegovy and Ozempic contain the same active drug, semaglutide, but they are not the same medication. Wegovy is approved for chronic weight management and is available in higher doses for this purpose. Ozempic is approved specifically to treat type 2 diabetes and to reduce cardiovascular risk in diabetic patients, though it often causes weight loss.

Nausea is a very common side effect of Wegovy, particularly when starting or increasing a dose. To manage it, try eating smaller, more frequent meals, choosing bland foods, and avoiding greasy or very sweet items. Staying hydrated is also helpful. If your nausea is severe or does not improve over time, you should consult your doctor for advice.

Wegovy helps regulate appetite, and studies show that weight regain is likely after stopping the medication if lifestyle changes are not maintained. The medication is a tool for chronic management. To keep weight off long-term, it is essential to continue with the healthy diet and exercise habits you developed while taking Wegovy. Your body's previous appetite levels may return after stopping.

Wegovy should not be used in combination with other prescription weight-loss drugs, over-the-counter supplements, or herbal products. It should also not be used with any other GLP-1 receptor agonist medicines. It is critical to inform your doctor of all medications and supplements you are taking so they can ensure there are no unsafe interactions with your treatment.

The Wegovy pen should be injected subcutaneously (just under the skin) in your abdomen, thigh, or upper arm. It is important to rotate your injection site each week. This practice helps prevent the skin from becoming irritated, lumpy, or sore. Your doctor or pharmacist will demonstrate the proper injection technique when you get your first prescription.

Wegovy carries a boxed warning from the FDA regarding a potential risk of thyroid C-cell tumors. In animal studies, semaglutide caused these tumors, but it is not known if this risk applies to humans. Because of this potential risk, Wegovy should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Wegovy is not safe to use during pregnancy because it has the potential to harm an unborn baby. It is recommended to stop taking Wegovy at least two months before you plan to become pregnant. If you find out you are pregnant while taking the medication, you should stop taking it and contact your doctor right away.